Moderna COVID-19 vaccine trial in kids ages 12 to 17 hits full enrollment

Moderna has completed enrollment for a Phase 2/3 study of its COVID-19 vaccine in adolescents ages 12 to 17.

from FOX News https://ift.tt/2NINPKL